BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 226 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,709,000 | -82.5% | 25,000 | -78.1% | 0.25% | -80.3% |
| Q4 2020 | $9,771,000 | +31.4% | 114,000 | -0.3% | 1.28% | -12.2% |
| Q3 2020 | $7,434,000 | -11.1% | 114,350 | 0.0% | 1.45% | -13.9% |
| Q2 2020 | $8,360,000 | -6.9% | 114,350 | -30.7% | 1.69% | -4.3% |
| Q4 2019 | $8,983,000 | +34.6% | 165,000 | +3.1% | 1.76% | -27.0% |
| Q3 2019 | $6,675,000 | +1.6% | 160,000 | +6.7% | 2.41% | +20.6% |
| Q2 2019 | $6,569,000 | – | 150,000 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |